Business
ASX 200 investors underexposed to this potential ‘great news event’ – Motley Fool Australia
If an effective vaccine against the coronavirus were uncovered this week, many ASX 200 investors would be poorly positioned to benefit.
The silver bullet to slay the coronavirus and return life to normal remains elusive. But that doesn’t mean it might not be here sooner than most S&P/ASX 200 Index (ASX: XJO) investors are pricing in.
The world’s top institutions and brightest minds are working around the clock, after all, with record amounts of private and government funding pouring in.
However, recent setbacks with some leading vaccine trials, alongside announcements that any new vaccines may only prove 50–60% effective, …
-
General14 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News15 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
General12 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?
-
Noosa News17 hours agoQueensland set for ‘comfortable’ weather over Easter long weekend